MiQuit Trial: Tailored Text Messages for Pregnant Women
MiQuit
Evaluation of a Tailored Text Message Intervention for Pregnant Smokers (MiQuit): a Pilot Trial
2 other identifiers
interventional
407
1 country
15
Brief Summary
The overall aim of the study is to estimate the likely impact of the MiQuit text message based smoking cessation service for pregnant smokers and to establish robust estimates for the key factors which would be required in order to design a larger definitive trial of this intervention(MiQuit). These key factors include: the range of recruitment rates in different centres; quit rates amongst participants; feasibility of assessing smoking status of participants in later pregnancy; and the likely effect of MiQuit when women are offered this in National Health Service (NHS) settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pregnancy
Started Feb 2014
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2014
CompletedFirst Posted
Study publicly available on registry
January 23, 2014
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedResults Posted
Study results publicly available
July 15, 2019
CompletedJuly 15, 2019
April 1, 2019
1.2 years
January 14, 2014
April 30, 2019
April 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Continuous Abstinence From Smoking Reported From 4 Weeks Post-randomisation Until Late Pregnancy, Biochemically Validated at Late Pregnancy.
The primary smoking outcome measure will be the number of participants reporting continuous abstinence from smoking from 4 weeks after randomisation until follow up at the end of pregnancy (approximately 36 weeks gestation), validated by exhaled CO and/or saliva cotinine estimation at approximately 36 weeks gestation.
36 weeks gestation
Secondary Outcomes (9)
Continuous Abstinence From Smoking Reported From 4 Weeks Post-randomisation Until Late Pregnancy, Self-report.
36 weeks gestation
7-day Point Prevalence Abstinence From Smoking Reported at Late Pregnancy, Self-report.
36 weeks gestation
7-day Point Prevalence Abstinence From Smoking Reported at Late Pregnancy, Biochemically Validated.
36 weeks gestation
7-day Point Prevalence Abstinence From Smoking Reported at 4 Weeks Post-randomization, Self-report.
4 weeks post-randomisation
7-day Point Prevalence Abstinence From Smoking Reported at Both 4 Weeks Post-randomization and at Late Pregnancy, Self-report.
36 weeks gestation
- +4 more secondary outcomes
Study Arms (2)
MiQuit
EXPERIMENTAL12 weeks of MiQuit text support plus a standard NHS leaflet giving information and advice on stopping smoking in addition to usual care
Control
NO INTERVENTIONUsual care plus the same standard NHS leaflet giving information and advice on stopping smoking
Interventions
MiQuit is an automated responsive text message support programme lasting 12 weeks which provides tailored smoking cessation support and advice to the participant's mobile phone. This support includes motivational messages, advice about preparing for a quit attempt, how to manage cravings and withdrawal, dealing with trigger situations, information about how smoking affects babies and general encouragement.
Eligibility Criteria
You may qualify if:
- Pregnant and less than 25 weeks gestation
- Smoking at least 5 cigarettes per day pre-pregnancy
- Smoking at least 1 cigarette on a typical day during pregnancy
- Aged 16 or over
- Agrees to accept information to assist cessation
- Has own or has primary use of a mobile phone
- Familiar with sending and receiving text messages
- Able to understand written English (text messages are in English only) and consent issues explained in English.
- Able to give informed consent
You may not qualify if:
- Already enrolled in another text service to assist smoking cessation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nottinghamlead
- University of Cambridgecollaborator
Study Sites (15)
Mid Cheshire Hospitals NHS Foundation Trust
Crewe, Cheshire, CW1 4QJ, United Kingdom
Chesterfield Royal Hospitals NHS Foundation Trust
Chesterfield, Derbyshire, S44 5BL, United Kingdom
Derby Hospitals NHS Foundation Trust
Derby, Derbyshire, DE22 3NE, United Kingdom
United Lincolnshire Hospitals NHS Trust
Boston, Lincolnshire, PE21 9QS, United Kingdom
United Lincolnshire Hospitals NHS Trust
Lincoln, Lincolnshire, LN12 5QY, United Kingdom
Nottingham University Hospitals NHS Trust, City Hospital
Nottingham, Nottinghamshire, NG5 1PB, United Kingdom
Nottingham University Hospitals NHS Trust, QMC
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
Sherwood Forest Hospitals NHS Foundation Trust
Sutton in Ashfield, Nottinghamshire, NG17 4JL, United Kingdom
University Hospital of North Staffordhsire NHS Trust
Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom
Birmingham Womens NHS Foundation Trust
Birmingham, W Midlands, B15 2TG, United Kingdom
Sandwell & West Birmingham Hospitals NHS Trust
Birmingham, West Midlands, B18 7QH, United Kingdom
The Dudley Group NHS Foundation Trust
Dudley, West Midlands, DY1 2HQ, United Kingdom
Heart of England NHS Foundation Trust
Birmingham, B9 5SS, United Kingdom
Central Manchester University Hosptitals NHS Foundation Trust
Manchester, M13 9WL, United Kingdom
University Hospitals North Midlands NHS Trust
Stafford, ST16 3SA, United Kingdom
Related Publications (2)
Naughton F, Prevost AT, Gilbert H, Sutton S. Randomized controlled trial evaluation of a tailored leaflet and SMS text message self-help intervention for pregnant smokers (MiQuit). Nicotine Tob Res. 2012 May;14(5):569-77. doi: 10.1093/ntr/ntr254. Epub 2012 Feb 6.
PMID: 22311960BACKGROUNDCooper S, Foster K, Naughton F, Leonardi-Bee J, Sutton S, Ussher M, Leighton M, Montgomery A, Parrott S, Coleman T. Pilot study to evaluate a tailored text message intervention for pregnant smokers (MiQuit): study protocol for a randomised controlled trial. Trials. 2015 Jan 27;16:29. doi: 10.1186/s13063-014-0546-4.
PMID: 25622639DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Joanne Emery
- Organization
- University of East Anglia
Study Officials
- STUDY CHAIR
Tim Coleman, Professor
University of Nottingham
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2014
First Posted
January 23, 2014
Study Start
February 1, 2014
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
July 15, 2019
Results First Posted
July 15, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share